Browsing eNauka
Browsing by Author Stojanovic, Miroslav
Showing results 1 to 9 of 9
| Issue Date | Title | Author(s) | Type | М-cat. |
|---|---|---|---|---|
| 2012 | Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial | Cohen, Jeffrey A; Coles, Alasdair J; Arnold, Douglas L; Confavreux, Christian; Fox, Edward J; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W; Weiner, Howard L; Fisher, Elizabeth;
Brinar, Vesna V; Giovannoni, Gavin; Stojanovic, Miroslav; Ertik, Bella I; Lake, Stephen L; Margolin, David H; Panzara, Michael A; Compston, D Alastair S;
| Article | 21aM21a |
| 2018 | Can we predict development of neuropathic pain in patients with chronic inflammatory demyelinating polyradiculoneuropathy? | Bjelica, Bogdan; Bozovic, Ivo; Peric, Stojan Z  ; Cobeljic, Mina; Stojanov, Aleksandar; Petrovic, Milutin; Dejanovic, Ivana; Marjanovic, Ivan V; Vukojevic, Zoran; Dominovic-Kovacevic, Aleksandra;
Stojanovic, Miroslav; Djordjevic, Gordana M; Basta, Ivana Z;
| Conference Paper | Mp. category will be shown later |
| 2012 | Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study | Arnold, Douglas L; Brinar, Vesna; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Fisher, Elizabeth; Fox, Edward; Giovannoni, Gavin; Hartung, Hans; Havrdova, Eva;
Selmaj, Krzysztof; Weiner, Howard; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2012 | Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients | Coles, Alasdair; Brinar, Vesna; Arnold, Douglas L; Cohen, Jeffrey; Confavreux, Christian; Fox, Edward; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof; Weiner, Howard;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2012 | Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I) | Havrdova, Eva; Arnold, Douglas L; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Fox, Edward; Hartung, Hans; Selmaj, Krzysztof; Weiner, Howard; Brinar, Vesna;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Oyuela, Pedro; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2018 | Influence of diabetes mellitus on chronic inflammatory demyelinating polyradiculoneuropathy | Cobeljic, Mina; ...; Stojanovic, Miroslav; ...; Rakocevic-Stojanovic, Vidosava M; Lavrnic, Dragana V; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2019 | Reconstructive Procedures after Total Gastrectomy for Gastric Cancer (✓) | Ignjatovic, Nebojsa  ; Randjelovic, Tomislav; Stojanovic, Miroslav; Stanojevic, Goran ; Đorđević, Miodrag | Book parts | Mp. category will be shown later |
| 2012 | Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints | Fox, Edward; Arnold, Douglas L; Brinar, Vesna; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Giovannoni, Gavin; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof;
Stojanovic, Miroslav; Weiner, Howard; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2016 | Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS | Arnold, Douglas L; ...; Stojanovic, Miroslav; ...; (broj, koautora 16) | Article | 21aM21a |